We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Dosing Strategies of Bone-Targeting Agents—Reply

Susan L. Greenspan, MD1; Subashan Perera, PhD1; Neil M. Resnick, MD1
[+] Author Affiliations
1Division of Geriatric Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
JAMA Intern Med. 2015;175(11):1865-1866. doi:10.1001/jamainternmed.2015.4799.
Text Size: A A A
Published online


In Reply We appreciate the comments by Hutton et al regarding dosing frequency and the need to examine alternative dosing intervals. Given our study design, which used a single infusion, we do not know whether a different dosing interval would have been more or less effective or generated more or fewer adverse events in this cohort. However, because a single infusion of zoledronic acid has been shown to exert a positive effect on skeletal health for up to 5 years,1,2 we chose a 2-year dosing interval. We agree that additional research needs to be done on the dosing frequency, especially focusing on frail elderly patients for whom there are limited data on osteoporosis treatment.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





November 1, 2015
Brian Hutton, PhD; Sasha Mazzarello, BSc; Mark Clemons, MD
1Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
2Division of Medical Oncology, Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada
JAMA Intern Med. 2015;175(11):1864-1865. doi:10.1001/jamainternmed.2015.4789.
November 1, 2015
Chika Edward Uzoigwe, MRCS, MRCP
1Department of Orthopaedics, Harcourt Building, Sheffield, United Kingdom
JAMA Intern Med. 2015;175(11):1865. doi:10.1001/jamainternmed.2015.4796.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...